A milestone was reached in the fight against HIV/AIDS with the development of Lenacapavir, a new injectable drug that ...

A new drug is hugely effective at protecting people from HIV infection and needs to be injected only twice a year.

A new long-acting preventive HIV drug could reach the world’s poorest countries by the end of 2025 or early 2026, a global ...

In news which headlined the AIDS 2024 conference ... represents a dramatic new alternative to the current standard of care ...

A drug used to treat HIV that has also shown promise in preventing ... which is caused by HIV infection. Posts saying, “New $40K AIDS cure is nearly 100% effective and requires two shots yearly ...

As the HIV/AIDS community looks ahead to a new era of long-acting antiretrovirals ... 31 But the makers of those drugs (Viiv and Johnson & Johnson, respectively) are not selling the combination ...

The next year brought the breakthrough that still defines HIV treatment today: highly active antiretroviral therapy (HAART). HAART uses three or more drugs that work in at least two different ways.

A significant breakthrough in treating the Human Immunodeficiency Virus (HIV) came recently with the US Federal Drug Administration (FDA) approving lenacapavir, a new prototype medication. It uses a ...

Uganda is registering around 38,000 new infections despite the deployment of different interventions such as condoms and oral ...

Over the past two years, the fight to reduced the number of new infections seems to have stagnated, with the country getting ...

LONDON, Dec 17 (Reuters) - A new long-acting preventive HIV drug could reach the world’s ... head of supply operations at the Global Fund to Fight AIDS, Tuberculosis and Malaria.